Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian L Harris

Showing results (301-310 of 443) with videos related to

Pageof 45
Sort By:
Cancer & Metabolism|February 13, 2024
Cone photoreceptor phosphodiesterase PDE6H inhibition regulates cancer cell growth and metabolism, replicating the dark retina responseCeren Yalaz, Esther Bridges, Nasullah K Alham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2017
A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer PatientsLingjian Yang, Janet Taylor, Amanda Eustace, et al.
International Journal of Oncology|July 13, 2005
Bone morphogenetic protein 2 (BMP-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cellsJoachim H Clement, Martin Raida, Jörg Sänger, et al.
Cancer Research|February 7, 2002
Metabolic changes detected by in vivo magnetic resonance studies of HEPA-1 wild-type tumors and tumors deficient in hypoxia-inducible factor-1beta (HIF-1beta): evidence of an anabolic role for the HIF-1 pathwayJohn R Griffiths, Paul M J McSheehy, Simon P Robinson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancerSrinivasan Madhusudan, Martin Foster, Sethupathi R Muthuramalingam, et al.
Journal of Oncology|July 24, 2010
Effects of HIF-1alpha and HIF2alpha on Growth and Metabolism of Clear-Cell Renal Cell Carcinoma 786-0 XenograftsSwethajit Biswas, Helen Troy, Russell Leek, et al.
Journal of Extracellular Vesicles|March 5, 2023
Accessory ESCRT-III proteins are conserved and selective regulators of Rab11a-exosome formationPauline P Marie, Shih-Jung Fan, John Mason, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Efficacy and toxicity of the angiogenesis inhibitor SU5416 as a single agent in patients with advanced renal cell carcinoma, melanoma, and soft tissue sarcomaBart C Kuenen, Jose Tabernero, Jose Baselga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Phase I study of copper-binding agent ATN-224 in patients with advanced solid tumorsSarah A Lowndes, Avril Adams, Anthony Timms, et al.
Cancers|April 13, 2023
Predicting Breast Cancer Events in Ductal Carcinoma In Situ (DCIS) Using Generative Adversarial Network Augmented Deep Learning ModelSoumya Ghose, Sanghee Cho, Fiona Ginty, et al.
Pageof 45

Showing results (301-310 of 443) with videos related to

Sort By:
Pageof 45
Cancer & Metabolism|February 13, 2024
Cone photoreceptor phosphodiesterase PDE6H inhibition regulates cancer cell growth and metabolism, replicating the dark retina responseCeren Yalaz, Esther Bridges, Nasullah K Alham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2017
A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer PatientsLingjian Yang, Janet Taylor, Amanda Eustace, et al.
International Journal of Oncology|July 13, 2005
Bone morphogenetic protein 2 (BMP-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cellsJoachim H Clement, Martin Raida, Jörg Sänger, et al.
Cancer Research|February 7, 2002
Metabolic changes detected by in vivo magnetic resonance studies of HEPA-1 wild-type tumors and tumors deficient in hypoxia-inducible factor-1beta (HIF-1beta): evidence of an anabolic role for the HIF-1 pathwayJohn R Griffiths, Paul M J McSheehy, Simon P Robinson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancerSrinivasan Madhusudan, Martin Foster, Sethupathi R Muthuramalingam, et al.
Journal of Oncology|July 24, 2010
Effects of HIF-1alpha and HIF2alpha on Growth and Metabolism of Clear-Cell Renal Cell Carcinoma 786-0 XenograftsSwethajit Biswas, Helen Troy, Russell Leek, et al.
Journal of Extracellular Vesicles|March 5, 2023
Accessory ESCRT-III proteins are conserved and selective regulators of Rab11a-exosome formationPauline P Marie, Shih-Jung Fan, John Mason, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Efficacy and toxicity of the angiogenesis inhibitor SU5416 as a single agent in patients with advanced renal cell carcinoma, melanoma, and soft tissue sarcomaBart C Kuenen, Jose Tabernero, Jose Baselga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Phase I study of copper-binding agent ATN-224 in patients with advanced solid tumorsSarah A Lowndes, Avril Adams, Anthony Timms, et al.
Cancers|April 13, 2023
Predicting Breast Cancer Events in Ductal Carcinoma In Situ (DCIS) Using Generative Adversarial Network Augmented Deep Learning ModelSoumya Ghose, Sanghee Cho, Fiona Ginty, et al.
Pageof 45